Antitumor activity of the oncolytic peptide LTX-315 in syngeneic tumor models

被引：0
|
作者：
Camilio, Ketil Andre
Sveinbjornsson, Baldur
Maubant, Sylvie
Serin, Guillaume
Mirjolet, Jean-Francois
Bichat, Francis
Rekdal, Oystein
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-328
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
328
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Synthesis and structural optimization of oncolytic peptide LTX-315
    Song, Min
    Liu, Qing
    Yao, Jing-Fang
    Wang, Yu-Tao
    Ma, Yan-Nan
    Xu, Huan
    Yu, Qian-Yao
    Li, Zhibo
    Du, Shan-Shan
    Qi, Yun-Kun
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 107
  • [2] LTX-315: A first-in-class oncolytic peptide that reshapes the tumor microenvironment
    Sveinbjornsson, Baldur
    Camilio, Ketil
    Wang, Meng-Yui
    Nestvold, Janne
    Maelandsmo, Gunhild
    Kvalheim, Gunnar
    Rekdal, Oystein
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [3] LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment
    Sveinbjornsson, Baldur
    Camilio, Ketil Andre
    Haug, Bengt Erik
    Rekdal, Oystein
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (12) : 1339 - 1344
  • [4] The oncolytic peptide LTX-315 triggers immunogenic cell death
    Zhou, H.
    Forveille, S.
    Sauvat, A.
    Yamazaki, T.
    Senovilla, L.
    Ma, Y.
    Liu, P.
    Yang, H.
    Bezu, L.
    Mueller, K.
    Zitvogel, L.
    Rekdal, O.
    Kepp, O.
    Kroemer, G.
    CELL DEATH & DISEASE, 2016, 7 : e2134 - e2134
  • [5] The oncolytic peptide LTX-315 triggers immunogenic cell death
    H Zhou
    S Forveille
    A Sauvat
    T Yamazaki
    L Senovilla
    Y Ma
    P Liu
    H Yang
    L Bezu
    K Müller
    L Zitvogel
    Ø Rekdal
    O Kepp
    G Kroemer
    Cell Death & Disease, 2016, 7 : e2134 - e2134
  • [6] The oncolytic peptide LTX-315 triggers necrotic cell death
    Forveille, Sabrina
    Zhou, Heng
    Sauvat, Allan
    Bezu, Lucillia
    Mueller, Kevin
    Liu, Peng
    Zitvogel, Laurence
    Pierron, Gerard
    Rekdal, Oystein
    Kepp, Oliver
    Kroemer, Guido
    CELL CYCLE, 2015, 14 (21) : 3506 - 3512
  • [7] Antitumor efficacy of the oncolytic peptide LTX-315 in genetic mouse models that resist conventional chemo- and immunotherapeutic treatments
    Pittet, Mikael J.
    Liao, Hsin-Wei
    Sveinbjornsson, Baldur
    Rekdal, Oystein
    CANCER RESEARCH, 2018, 78 (13)
  • [8] LTX-315 - a promising novel antitumor peptide and immunotherapeutic agent
    Zweytick, Dagmar
    CELL STRESS, 2019, 3 (11) : 328 - 329
  • [9] The oncolytic peptide LTX-315 enhances T cell clonality and induces synergy with chemotherapy
    Camilio, Ketil Andre
    Wang, Meng Yu
    Nestvold, Janne
    Maelandsmo, Gunhild
    Sveinbjornsson, Baldur
    Rekdal, Oystein
    CANCER RESEARCH, 2017, 77
  • [10] Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide
    Haug, Bengt Erik
    Camilio, Ketil Andre
    Eliassen, Liv Tone
    Stensen, Wenche
    Svendsen, John Sigurd
    Berg, Kristel
    Mortensen, Bjarte
    Serin, Guillaume
    Mirjolet, Jean-Francois
    Bichat, Francis
    Rekdal, Oystein
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (07) : 2918 - 2927
12345